Delivery Order SPE2DB25D3005-SPE2DB25FQKDF
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $2,044.50 for Spiriva Respimat 1.25 mcg inhalation solution, a respiratory medication used to treat chronic obstructive pulmonary disease. The contract is classified as firm fixed price with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,107.10 to AmerisourceBergen Drug Corp on August 6, 2025, for Spiriva Respimat 1.25 mcg inhaler 4gm, a respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by August 7, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The order represents a...
- The Defense Logistics Agency awarded a $1,042.65 delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication (4 gm) with an ultimate completion date of August 1, 2025. This competitive award, utilizing firm fixed pricing, was issued with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,639.67 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation solution (4 gm) on September 26, 2025, with completion scheduled for September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,086.49 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication used to treat chronic obstructive pulmonary disease. Issued on August 8, 2025, with a completion deadline of August 11, 2025, this firm fixed price delivery order represents a routine pharmaceutical procurement under a non-competitive set-aside arrangement. The order will be fulfilled from AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams) with a ceiling value of $1,629.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by September 15, 2025, with fulfillment from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,844.50 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution (4 gm). This competitively awarded, firm fixed-price contract has a completion date of June 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalant (4 gm) with a ceiling value of $1,651.33. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.12 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4gm) with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition in federal procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQKDFDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,668.24 for Spiriva Respimat 1.25 mcg inhaler 4gm, a respiratory medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's demonstrated capability to compete successfully in the federal medical supply procurement marketplace. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle supplying the full spectrum of medications, vaccines, and medical supplies to military healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal portfolio delivering critical medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/26/25 |